Hiroko Ishibashi Selected Research

Oral Candidiasis (Thrush)

3/2012	A D-octapeptide drug efflux pump inhibitor acts synergistically with azoles in a murine oral candidiasis infection model.
1/2012	The essential oil of Melaleuca alternifolia (tea tree oil) and its main component, terpinen-4-ol protect mice from experimental oral candidiasis.
1/2010	[Therapeutic effect of oligonol, a low-molecular polyphenol formulation derived from lychee fruits on murine oral candidiasis].
1/2010	Therapeutic effects on murine oral candidiasis by oral administration of cassia (Cinnamomum cassia) preparation.
7/2008	Protective effects of farnesol against oral candidiasis in mice.
2/2008	Oral candidiasis deteriorated by local application of a glucocorticoid-containing film in a mouse model.
3/2007	A novel murine model of pharyngeal candidiasis with local symptoms characteristic of pharyngeal thrush produced by using an inhaled corticosteroid.
2/2007	Oral administration of itraconazole solution has superior efficacy in experimental oral and oesophageal candidiasis in mice than its intragastric administration.
6/2004	Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model.
8/2003	Oral lactoferrin treatment of experimental oral candidiasis in mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroko Ishibashi Research Topics

Disease

11	Oral Candidiasis (Thrush) 03/2012 - 01/2003
10	Candidiasis (Moniliasis) 03/2012 - 01/2003
9	Infections 03/2012 - 01/2003
3	Inflammation (Inflammations) 08/2008 - 10/2005
2	Neoplasms (Cancer) 06/2008 - 09/2006
2	Edema (Dropsy) 01/2006 - 10/2005
1	Body Weight (Weight, Body) 06/2008
1	Lewis Lung Carcinoma 06/2008
1	Neoplasm Metastasis (Metastasis) 06/2008
1	Invasive Pulmonary Aspergillosis 12/2006
1	Experimental Arthritis 01/2006

Drug/Important Bio-Agent (IBA)

4	Volatile Oils (Essential Oils)IBA 01/2012 - 10/2005
3	Itraconazole (Sporanox)FDA LinkGeneric 03/2012 - 12/2006
2	AzolesIBA 03/2012 - 01/2012
2	Prednisolone (Predate)FDA LinkGeneric 01/2012 - 06/2004
2	Therapeutic UsesIBA 01/2010 - 01/2010
2	Beclomethasone (Beclometasone)FDA Link 02/2008 - 03/2007
2	Antifungal AgentsIBA 01/2007 - 01/2003
2	Hypnotics and Sedatives (Sedatives)IBA 01/2007 - 01/2003
2	Milk Proteins (Milk Protein)IBA 06/2004 - 08/2003
2	LactoferrinIBA 06/2004 - 08/2003
1	Pharmaceutical PreparationsIBA 03/2012
1	Tea Tree OilIBA 01/2012
1	terpinenol-4IBA 01/2012
1	Fluconazole (Zonal)FDA LinkGeneric 01/2012
1	oligonolIBA 01/2010
1	TeaIBA 01/2010
1	PolyphenolsIBA 01/2010
1	Plant Preparations (Preparation, Plant)IBA 01/2010
1	geraniol (nerol)IBA 08/2008
1	FarnesolIBA 07/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2008
1	InterferonsIBA 06/2008
1	GlucocorticoidsIBA 02/2008
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2007
1	CyclodextrinsIBA 02/2007
1	hydroxide ionIBA 02/2007
1	hydroxyitraconazoleIBA 02/2007
1	SolutionsIBA 02/2007
1	Chlorpromazine (Thorazine)FDA Link 01/2007
1	2-Hydroxypropyl-beta-cyclodextrinIBA 12/2006
1	PowdersIBA 09/2006
1	Interferon-gamma (Interferon, gamma)IBA 09/2006
1	Peroxidase (Myeloperoxidase)IBA 01/2006
1	CollagenIBA 01/2006
1	CarrageenanIBA 01/2006
1	polyglucosanIBA 10/2005
1	curdlanIBA 10/2005
1	CytokinesIBA 06/2004
1	Drinking WaterIBA 08/2003
1	lemongrass oilIBA 01/2003

Therapy/Procedure

4	Oral Administration 01/2010 - 01/2003
1	Therapeutics 03/2012
1	Intravenous Administration 12/2006
1	Intraperitoneal Injections 01/2006
1	Aromatherapy 01/2006